Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

Autres documents

C2190000

Ciprofloxacin hydrochloride

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

Ciprofloxacin hydrochloride monohydrate

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C17H18FN3O3 · HCl · H2O
Numéro CAS:
86393-32-0
Poids moléculaire :
385.82
Numéro MDL:
MFCD00242856
Code UNSPSC :
41116107
ID de substance PubChem :
329774976
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

ciprofloxacin

Fabricant/nom de marque

EDQM

Technique(s)

HPLC: suitable
gas chromatography (GC): suitable

Application(s)

pharmaceutical (small molecule)

Format

neat

Chaîne SMILES 

O.Cl.OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O

InChI

1S/C17H18FN3O3.ClH.H2O/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24;;/h7-10,19H,1-6H2,(H,23,24);1H;1H2

Clé InChI

ARPUHYJMCVWYCZ-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Ciprofloxacin hydrochloride EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

PHR1044

Ciprofloxacin HCl, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1174

Fluoroquinolonic acid, Pharmaceutical Secondary Standard; Certified Reference Material

1134324

Ciprofloxacin Ethylenediamine Analog, United States Pharmacopeia (USP) Reference Standard

1278302

Fluoroquinolonic acid, United States Pharmacopeia (USP) Reference Standard

Y0000198

Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard

Y0000199

Ciprofloxacin hydrochloride for peak identification, European Pharmacopoeia (EP) Reference Standard

1134459

Ciprofloxacin formamide, United States Pharmacopeia (USP) Reference Standard

1134346

Ciprofloxacin Related Compound A, United States Pharmacopeia (USP) Reference Standard

1134313

Ciprofloxacin, United States Pharmacopeia (USP) Reference Standard

BP930

Ciprofloxacin impurity standard, British Pharmacopoeia (BP) Reference Standard

BP929

Ciprofloxacin hydrochloride, British Pharmacopoeia (BP) Reference Standard

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Roles of the superoxide dismutase SodB and the catalase KatA in the antibiotic resistance of Campylobacter jejuni.
Sunyoung Hwang et al.
The Journal of antibiotics, 66(6), 351-353 (2013-04-04)
Kathryn E Holt et al.
Proceedings of the National Academy of Sciences of the United States of America, 110(43), 17522-17527 (2013-10-02)
Shigella sonnei is a human-adapted pathogen that is emerging globally as the dominant agent of bacterial dysentery. To investigate local establishment, we sequenced the genomes of 263 Vietnamese S. sonnei isolated over 15 y. Our data show that S. sonnei
E M Jones et al.
The Veterinary record, 173(17), 422-422 (2013-10-08)
Four models are presented investigating risks present on Great Britain (GB) turkey farms in breeding and fattening flocks for ciprofloxacin and cephalosporin resistance. Risk factors for ciprofloxacin resistance in fattening flocks were sourcing of feed from national compounders, antimicrobial use
Julie Papillon et al.
Nucleic acids research, 41(16), 7815-7827 (2013-06-28)
Type 2A DNA topoisomerases (Topo2A) remodel DNA topology during replication, transcription and chromosome segregation. These multisubunit enzymes catalyze the transport of a double-stranded DNA through a transient break formed in another duplex. The bacterial DNA gyrase, a target for broad-spectrum
Pieter Dewint et al.
Gut, 63(2), 292-299 (2013-03-26)
To assess whether a combination of adalimumab and ciprofloxacin is superior to adalimumab alone in the treatment of perianal fistulising Crohn's disease (CD). Randomised, double-blind, placebo controlled trial in eight Dutch hospitals. In total, 76 CD patients with active perianal
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique